Shilpa Medicare Reports Strong 2QFY27 Performance Driven by Broad-Based Segment Growth
Shilpa Medicare Ltd 路 Investor Presentation 路 05 Nov 2026, 6:49 pm
Shilpa Medicare Reports Strong 2QFY27 Performance Driven by Broad-Based Segment Growth Shilpa Medicare delivered record quarterly revenue of INR 538 cr, up 45% YoY and 15% QoQ in 2QFY27, while EBITDA rose 37% YoY to INR 151 cr with a 28% margin. PAT surged 80% YoY to INR 79 cr. For 1HFY27, revenue reached INR 1,007 cr (+44% YoY) and PAT nearly doubled to INR 180 cr (+98% YoY). Growth was led by API (47% share) and Formulations (39% share). Net debt to EBITDA improved to 1.3x and adjusted ROCE expanded to 18.2%.
Original exchange filing (PDF)
More announcements from Shilpa Medicare Ltd
- Q2FY27 Earnings Conference Call 05 November 2026 路 11 Nov 2026
- Audio link of the Investor Conference call for the quarter ended 30 September 2026. 路 06 Nov 2026
- Update on Corporate Insolvency Resolution Process of FTF Pharma Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Shilpa Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Financial Results for the Quarter and Half year ended 30 September 2026 路 05 Nov 2026
- SHILPA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
